- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03073993
Nasogastric Versus Orogastric Route of Feeding in Preterm (<32 Weeks) Neonates
Enteral feeding tubes in newborns are used for feeding preterm and low birth weight babies in neonatal intensive care units as they often do not suck effectively owing to lack of coordination between sucking, swallowing and breathing due to neurological immaturity and delayed gastric emptying.
The feeding tubes could be inserted by the nasogastric (NG) route or by the orogastric (OG) route. Both routes are used in different Neonatal Intensive Care Units (NICUs). Both methods are associated with different adverse events.
Since newborn infants are obligate nose breathers, nasogastric tube (NGT) can lead to partial nasal obstruction which might increase airway resistance and work of breathing although they are easy to secure to the face than orally placed tubes. Orogastric tubes (OGT), on the other hand, may not lead to the potential risk of increased work of breathing associated with NGT but are more frequently malpositioned and can loop inside the mouth. Also there is increased possibility of apnea and bradycardia due to vagal stimulation.
Despite so many years of continuing debate, the evidence of superiority of one method over another is not proven. Very few studies have tried to look into this matter and there are no consensus guidelines. This study is being conducted to compare the rate and type of adverse events in OG versus NG feeds in preterm neonates ≤ 32 weeks and postmenstrual age (PMA) ≤ 36 weeks.
Preterm neonates born at ≤ 32 weeks with PMA≤ 36 weeks who require feeding tube as a route for enteral feeding once they are out of respiratory support ( i.e ventilation or CPAP) are eligible candidates. Feeding tube insertion episode (FTIE) is defined as episode of insertion of OG or NG tube. FTIE will be randomized into NG or OG routes. Primary outcome is frequency of desaturation and bradycardia in each group.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
After written informed consent by either of the parent, preterm neonate (≤32 weeks gestational age and PMA ≤36weeks) fulfilling the inclusion criteria will be enrolled in the study if they require tube feeding.
Each episode of insertion of either NGT or OGT will be labelled as Feeding tube insertion episode (FTIE) in the study. Total of 160 FTIE will be done in study period, 80 FTIEs in preterm neonates of <30 weeks gestational age and 80 FTIE in preterm neonates of ≥30 weeks gestational age.
The method of FTIE (whether NG or OG) will be randomized into 2 groups by computer generated random sequence in blocks of 4 each. Stratification will be done as per Gestational age< 30 weeks and ≥ 30 weeks. Randomization sequence will be stored in sealed opaque envelope which was kept with one person who will not involved in care of patients.
Tube insertion will be done by NICU nursing staff who are already trained and validated in putting tube. Length of NGT/OGT insertion will be calculated by distance from bridge of nose to ear lobe and then from ear lobe to midway between xiphisternum and umbilicus (NEMU method). Correct tube placement will be checked by first aspirating and then pushing in 2 ml air and listening by stethoscope.
Each FTIE will be followed till the tube required to be changed for any reason, or tube feeding terminated due to graduation to direct feeds by paladay or breast. If the tube is changed for any reason, the reinsertion of the tube will be taken as a fresh FTIE, and again followed as above.
To record adverse events, heart rate and oxygen saturations will be recorded in the monitor till the time tube remained in situ. Bradycardia is defined as Heart rate < 100/min. Desaturation is defined as SpO2 < 85%. Alarms on the multifunction monitors (Philips MP 20 Neonatal) will be set with lower limit of Heart rate as 100/min and lower limit of saturation as 85%. Episodes will be recorded on a proforma lying at bedside by the duty nurse on the data collection form which include demographic parameters notably name, age, sex, IP No, gestational age at birth in weeks+ days, PMA at enrollment (weeks+ days), method of feeding (OG or NG) along with clinical parameters in the form of desaturation episodes/hr and bradycardia episodes/hr.
If a tube remained in situ for more than 24 hours, a new sheet will be taken. Each time monitor give alarm for desaturation and/ or bradycardia, nurse will check the baby and monitor. If the waveform showed regular trend and probe is attached properly to baby, episode will be recorded. Since the duration of NG and OG tubes may vary, the number of episodes of bradycardia and /or desaturation episodes/hr will be compared.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Hemodynamically stable preterm neonates (≤32 weeks gestational age and PMA ≤ 36weeks) not requiring respiratory support (CPAP/Heated humidified high flow oxygen/ Ventilation).
Exclusion Criteria:
- Babies (> 32 weeks and PMA>36 weeks)
- Severe congenital malformations, chromosomal abnormalities
- Baby requiring any respiratory support
- Sepsis, IVH, NEC or any illness explaining apneas
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Nasogastric
Feeding tube insertion in nasogastric group
|
Feeding tube was inserted in hemodynamically stable babies for purpose of feeding
|
|
Active Comparator: Orogastric
Feeding tube insertion in orogastric group
|
Feeding tube was inserted in hemodynamically stable babies for purpose of feeding
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Heart rate and saturation
Time Frame: 48 hours
|
frequency of episodes of heart rate <100 and sauration < 85%
|
48 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
infant feeding tube
Time Frame: 48 hours
|
duration in hours after which it needs to be changed.
We want to see whether nasogastric tube remains in situ for longer time or vice versa
|
48 hours
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Naveen P Gupta, MD, DNB, Consultant Neonatologist
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NGOG
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Apnea Prematurity
-
Uludag UniversityRecruitingApnea of Prematurity | Apnea NeonatalTurkey (Türkiye)
-
Assiut UniversityNot yet recruitingApnea of Prematurity | Preterm Neonates
-
University of California, IrvineActive, not recruiting
-
University of ManitobaCanadian Institutes of Health Research (CIHR); The Children's Hospital Foundation...Completed
-
Children's Hospital of Fudan UniversityCompletedApnea of Prematurity
-
NobelpharmaCompleted
-
Daping Hospital and the Research Institute of Surgery...Unknown
-
McMaster UniversityNational Health and Medical Research Council, Australia; Canadian Institutes...CompletedApnea of PrematurityCanada, United States, Israel, Australia, Netherlands, United Kingdom, Switzerland, Germany, Sweden
-
Ain Shams UniversityUnknown
-
University Hospital TuebingenTerminatedApnea of Prematurity | Continuous Positive Airway Pressure | CPAP
Clinical Trials on feeding tube insertion
-
Hillel Yaffe Medical CenterCompletedInfant, PrematureIsrael
-
University of PittsburghNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Terminated
-
Sunnybrook Health Sciences CentreThe Physicians' Services Incorporated FoundationCompletedApnea | Infant, PrematureCanada
-
Andrew Hendifar, MDCompletedPancreatic Neoplasms | Pancreatic Cancer | Weight Loss | CachexiaUnited States
-
Children's Hospital of PhiladelphiaEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingGastroesophageal Reflux | Bronchopulmonary DysplasiaUnited States
-
Copka SonpashanNot yet recruitingCerebral Small Vessel Diseases
-
MuhammadCompleted
-
The University of Texas Health Science Center,...TerminatedEnteral Feeding in BronchiolitisUnited States
-
Copka SonpashanNot yet recruitingPierre Robin Syndrome
-
Zeng ChanghaoTerminatedNasopharyngeal CarcinomaChina